|
Let your food be your medicine, and your medicine be your food. ...Hippocrates |
|
|
Soy phytoestrogens, osteoporosis and menopausal women
Page 7 of 7
References
| 1. | Barrett CE: Epidemiology and the menopause:A global overview. Int J Fertil 1993, 38:6-14. |
|
| 2. | Dempster DW, Lindsay R: Pathogenesis of osteoporosis. Lancet 1996, 341:797-801. [Publisher Full Text] |
|
| 3. | Position statement of the north american menopause society: Management of postmenopausal osteoporosis. Menopause 2002, 9(2):84-101. [PubMed Abstract] [Publisher Full Text] |
|
| 4. | Scharbo DM: Hormone replacement therapy. Nurse Pract 1996, 21:1-13. [PubMed Abstract] |
|
| 5. | Groeneveld FP, Bareman FP, Barensen r, et al.: Determinants of first prescription of hormone replacement therapy. A follow up study among 1689 women aged 45–60 years. Maturitas 1994, 20:81-89. [PubMed Abstract] [Publisher Full Text] |
|
| 6. | Lignieres DB: Hormone replacement therapy: clinical benefits and side-effects. Maturitas 1996, (suppl 23):31-36. [Publisher Full Text] |
|
| 7. | Glazier MG, Bowman MA: A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001, 161:1161-1172. [PubMed Abstract] [Publisher Full Text] |
|
| 8. | Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, et al.: A comparison of hip frcture incidence amonge native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 1991, 133:801-809. [PubMed Abstract] |
|
| 9. | Adlercreutz H, Mazur W: Phytoestrogens and Western diseases. Ann Med 1997, 29:95-120. [PubMed Abstract] |
|
| 10. | Simoon F: Food in china: a cultural and historical inquiry. Boca Raton, FL: CRC press Inc; 1991. |
|
| 11. | Kurzer MS, Xu X: Dietary phytoestrogens. Ann Rev Nutr 1997, 17:353-381. [Publisher Full Text] |
|
| 12. | Coward L, Barnes NC, Setchell EDR, Barnes S: Genistein, daidzein and their β-glucoside conjugates: antitumor isoflavones in soybean foods from American diets and Asian diets. J Agri Food Chem 1993, 41:1961-1967. [Publisher Full Text] |
|
| 13. | Messina MJ: Legumes and soybeans: Overview of their nutritional profiles and health effects. Am J Clin Nutr 1999, (suppl 70):439-450. |
|
| 14. | Wangen KE, Duncan AM, Merz-Demlow BE, et al.: Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000, 85:3043-3048. [PubMed Abstract] [Publisher Full Text] |
|
| 15. | Kuiper GG, Carisson B, Grandien K, et al.: Comparison of the ligand binding specifity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870. [PubMed Abstract] [Publisher Full Text] |
|
| 16. | National Nutrition Institute: National food consumption survey report. Tehran, Iran. 1995. |
|
| 17. | Watts NB: Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999, 45(8 Pt 2):1359-1368. [PubMed Abstract] [Publisher Full Text] |
|
| 18. | Arjmandi BH, Alekel L, Hollis BW, Amin D, et al.: Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nut 1996, 126:161-167. |
|
| 19. | Arjmandi BH, Getlinger MJ, Goyal NV, Alekel l, Hasler CM, et al.: Role of soy protein with normal or reduced isoflaonecontent in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998, (suppl 68):1358-1363. |
|
| 20. | Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, et al.: Bone sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 1998, (suppl 68):1364-1368. |
|
| 21. | Chang YC, Nair MG: Metabolism of daidzein and genistein by intestinal bacteria. J Nutr Proc 1995, 58:1892-1896. |
|
| 22. | Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S: Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995, 125:2307-2315. [PubMed Abstract] |
|
| 23. | Sathyamoorthy N, Wang TTY: Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 1997, 33:2384-2389. [PubMed Abstract] [Publisher Full Text] |
|
| 24. | Setchell KDR, Adlercreutz H: Mammalian lignans and phytoestrogens: recent studies on their formation, metabolism, and biological role in health and disease. In Role of the gut flora in toxicity and cancer. Edited by: Rowland IR. Academic Press. London, United Kingdom; 1988:315-345. |
|
| 25. | Register TC, Jayo MJ, Anthony MS: Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. J Clin Endocrinol Metab 2003, 88:4362-4370. [PubMed Abstract] [Publisher Full Text] |
|
| 26. | Clarkson TB, Anthony MS, Morgan TM: Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001, 86(1):41-47. [PubMed Abstract] [Publisher Full Text] |
|
| 27. | Setchell KD, Brown NM, Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002, 132(12):3577-3584. [PubMed Abstract] [Publisher Full Text] |
|
| 28. | Arjmandi Bh, Khalil DA, Smith BJ, et al.: soy protein has a greater effect on bone in postmenopausalwomen not on hormon replacement therapy as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 2003, 88:1048-1054. [PubMed Abstract] [Publisher Full Text] |
|
| 29. | Yamori Y, Moriguchi EH, Teramoto T, Miura A, et al.: Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil:A ten week study. J Am Coll Nutr 2002, 21(6):560-563. [PubMed Abstract] [Publisher Full Text] |
|
| 30. | Picherit C, Pelissero CB, Chanteranne B, Lebecque P, et al.: Soybean isofavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 2001, 131:723-728. [PubMed Abstract] [Publisher Full Text] |
|
| 31. | Uesugi T, Fukui Y, Yamori Y: Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four week study. J Am Coll Nutr 2002, 21:97-102. [PubMed Abstract] [Publisher Full Text] |
|
| 32. | Fanti P, Monier-Faugere MC, Geng Z, et al.: The phytoestrogen genistein reduces bone loss in short term ovariectomized rats. Osteoporosis Int 1998, 8:274-281. [Publisher Full Text] |
|
| 33. | Agnusdei D, Crepaldi G, Isaia G, et al.: A double blind, placibo controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss. Calcif Tissue Int 1997, 61:142-147. [PubMed Abstract] [Publisher Full Text] |
|
| 34. | Gennari C, Agnusdei D, Crepaldi G, et al.: Effect of ipriflavone-a synthetic derivative of natural isoflavones-on bonemass loss in the early years after menopause. Menopause 1998, 5:9-15. [PubMed Abstract] |
|
| 35. | Potter SM, Baum JA, Teng H, Stillman RJ, et al.: Soy protein and isoflavone: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998, 68(suppl 6):1375-1379. |
|
| 36. | Alekel DL, Germain AS, Peterson CT, Hanson KB, et al.: Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopusal women. Am J Clin Nutr 2000, 72:844-852. [PubMed Abstract] [Publisher Full Text] |
|
| 37. | Barnes S: Phytoestrogens and osteoporosis – What is a safe dose? Br J Nutr 2003, 39:101-108. |